The opportunity to eliminate hepatitis C virus (HCV) is at hand, but challenges across the care continuum persist. These challenges are particularly poignant for persons co-infected with HIV, who are a high-priority to cure but historically not well engaged in HCV care. Case management interventions have shown success in linking patients to HIV care. We hypothesized that a strengths-based nurse case management intervention (Care2Cure) adapted from evidence-based HIV studies could improve HCV care continuum outcomes for persons with HIV/HCV co-infection.
We conducted a prospective, single-blinded, randomized controlled trial to test the effect of Care2Cure in 68 adults (intervention n=35 and control n=33) with HIV/HCV co-infection. The Care2Cure intervention consisted of nurse-initiated referral to HCV care, scheduling assistance in the HCV practice, and HCV education. The comparison group (usual care) received an HCV fact sheet only. Primary outcomes included 1) linkage to HCV care (i.e., attendance at an HCV clinic appointment within 60 days of enrollment) and 2) time to DAA initiation (number of days from enrollment to first dose of DAAs). Study participants were followed for 6 months.
Our sample was predominantly Black/African American (81%) and low income (85% Medicaid). Nearly half (46%) reported illicit drug use and 43% had an undetectable HIV viral load. There were no demographic differences between groups at baseline. At day 60, a greater proportion of participants in the Care2Cure arm linked to HCV care (47%) compared to the comparison arm (25%) (p=0.036 by z test for difference in proportions; 95% confidence bound=3.2-40.9%). Among participants who initiated HCV treatment (n=12), the median time to DAA initiation was 100 days (interquartile range 69.5-118.5 days), with a median of 72 days for participants in the Care2Cure arm and 98 days for those in the comparison arm. This did not result in a significant difference in time to treatment initiation between the two arms at 6 months by logrank test (p=0.192).
Our results support provision of nurse case management as a successful strategy to link persons co-infected with HIV to HCV care. Nonetheless, linking to care alone is not sufficient to cure HCV in those who remain untreated. Interventions that address the intersection of HCV and HIV that continue from linking to care through treatment initiation and cure are needed to achieve HCV elimination in this high-priority population.